Cardiovascular Systems says it closed enrollment in the Japanese arm of its coronary orbital atherectomy system trial.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/11JMWnt
Cardiovascular Systems says it closed enrollment in the Japanese arm of its coronary orbital atherectomy system trial.
The FDA grants pre-market approval to Johnson & Johnson's Animas Vibe insulin pump, which uses DexCom's G4 platinum continuous glucose monitoring sensor.
More than 100 companies, a quarter of them medical device firms, were the targets of a sophisticated hacking operation into their executives' email accounts, according to cybersecurity firm FireEye.
(Reuters) — Security researchers say they have uncovered a cyber espionage ring focused on stealing corporate secrets for the purpose of gaming the stock market, in an operation that has compromised sensitive data about dozens of publicly held companies.
Kickback allegations against its former editor prompted the Journal of Patient Safety to review his writings and adopt new standards for disclosing commercial conflicts of interest.
Dr. Chuck Denham delivers a keynote address to the Cleveland Clinic in 2011. Denham, once a golden figure in the burgeoning patient safety movement, has faced kickback allegations and now a review of articles he wrote for the Journal of Patient Safety. (SafetyLeaders/Flickr)
by Marshall Allen, ProPublica
GI Dynamics says it can restart sales of its EndoBarrier weight loss device in Europe, having resolved concerns over use guidelines and how it reports adverse events.
The Emergo Group Blog provides short updates on quality and regulatory topics that may be of interest to QA/RA professionals in the medical device and IVD industry. No fluff, just straight to the point. We hope you'll enjoy the content.
By Stewart Eisenhart, Emergo Group
South Korea's Ministry of Food and Drug Safety (MFDS) identified certain raw materials prohibited from use in medical device production.
Anti-trust regulators in Europe clear Medtronic's $43 billion acquisition of Covidien.